Condition | Cancer

Alliance A031501

  • IRB Number: Alliance A031501
  • Contact Name: Blair Thomas, RN BSN
  • Status: Enrolling
  • Phone: (585) 747-4555
  • Lead Researcher: Maria Sbenghe, MD

Description

Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) versus Observation. https://www.clinicaltrials.gov/ct2/show/NCT03244384